• Endothelial STING–JAK1 Signaling in Tumor Immunity

  2026-09-24

  A 2025 study identifies endothelial STING as a driver of type I interferon-dependent JAK1–STAT signaling, tumor-vessel normalization, and CD8+ T-cell infiltration. Its findings extend the conventional view of STING and suggest that the vascular compartment should be considered when evaluating STING-based antitumor strategies.

• EGCG Nanoparticles Sensitize FLASH Radiotherapy

  2026-09-24

  This study reports that self-assembled EGCG nanoparticles (BENPs) can increase FLASH-RT-associated oxidative stress and DNA damage in a 4T1 breast cancer model, while strengthening antitumor and immune effects. The findings support further testing of nanoparticle-assisted FLASH radiotherapy, but do not yet establish clinical benefit or define a validated human treatment protocol.

• Carcinogen-Induced seRNA Drives NPC Metastasis

  2026-09-23

  A 2023 study links the carcinogen DNP to increased expression of seRNA-NPCm, which promotes nasopharyngeal carcinoma metastasis through an NPM1/c-Myc/NDRG1 transcriptional pathway. The work combines transcriptomic and chromatin profiling with functional experiments, while leaving important questions about clinical validation and the context-dependent role of NDRG1 unresolved.

• BicD and MAP7 Cooperatively Activate Kinesin-1

  2026-09-23

  This bioRxiv preprint shows that Drosophila BicD and MAP7 activate homodimeric kinesin-1 through complementary mechanisms rather than redundant ones. BicD appears to relieve kinesin autoinhibition, whereas MAP7 improves microtubule recruitment and run length, providing a mechanistic framework for bidirectional motor regulation.

• SCH772984 HCl: A Causal ERK Signaling Probe

  2026-09-22

  SCH772984 HCl is an ERK1/2 inhibitor for testing how MAPK activity controls tumor behavior and gene transcription. This article connects its cancer-research utility with an isoform-aware KLF4–AgRP study to improve causal assay design.

• γH2AX in Translational Radiotherapy Research

  2026-09-22

  A mechanistic and strategic guide to using γ-H2AX immunofluorescence to connect radiotherapy-induced DNA damage with tumor response, repair biology, and translational decision-making.

• CF10–EdU Synergy Drives Telomere Attrition

  2026-09-21

  The 2026 NAR Molecular Medicine study shows that the fluoropyrimidine polymer CF10 strongly synergizes with EdU by increasing EdU incorporation, DNA double-strand breaks, telomere loss, and mitotic catastrophe in colorectal cancer cells. Its main practical contribution is a mechanistic framework linking thymidylate stress to telomere dysfunction rather than treating combination activity as nonspecific cytotoxicity.

• Tiamulin (Thiamutilin) Research Workflows

  2026-09-21

  Tiamulin (Thiamutilin) combines ribosomal antibacterial activity with a research-relevant anti-inflammatory profile, making it useful for pathogen susceptibility studies and inflammation-focused cell assays. This guide connects practical formulation, MIC/FIC testing, PK-aware study design, and troubleshooting to support reproducible veterinary and translational workflows.

• Topotecan HCl for DNA Damage Research

  2026-09-20

  Topotecan HCl converts topoisomerase I stress into measurable replication damage, making it useful for cancer-cell viability, sphere-forming, and apoptosis workflows. This guide connects dose timing, formulation, and troubleshooting with a recent study of selective neuronal vulnerability while clearly separating established evidence from exploratory applications.

• NF449 and Selective Platelet P2X1 Blockade

  2026-09-19

  The reference study established NF449 as a comparatively selective antagonist of platelet P2X1 receptors and used it to separate P2X1, P2Y1, and P2Y12 contributions to platelet activation. Its ex vivo and in vivo experiments linked P2X1 blockade to reduced collagen-driven aggregation and thrombus formation, while showing that selectivity and bleeding effects depended strongly on dose.

• SMPD4, Ceramide, and Primary Cilia in Brain Development

  2026-09-18

  The 2024 Development study identifies SMPD4-dependent ceramide production as a mechanistic link between sphingolipid metabolism, primary cilia integrity, and brain development. By combining mouse genetics with human induced pluripotent stem cell models and ceramide rescue experiments, it connects SMPD4 loss to Purkinje cell failure, cerebellar hypoplasia, neural progenitor death, and shortened primary cilia.

• β-NMN and Diabetic Cardiac Fibrosis Research

  2026-09-18

  Explore how beta-Nicotinamide mononucleotide (β-NMN) can connect NAD+ metabolism with diabetic cardiac fibrosis research. This guide translates recent SIRT3–GSK3β–Smad3 findings into practical assay and experimental-design decisions.

• Lovastatin Workflow for Cell Signaling Research

  2026-09-17

  Build a controlled Lovastatin workflow that connects HMG-CoA reductase inhibition with proliferation, apoptosis, macrophage efferocytosis, and wound-repair phenotypes. The guide also translates a plant meristem study into practical time-resolved assay design without overstating cross-domain evidence.

• Engineering mRNA for Neuroimmune Translation

  2026-09-17

  The path from T7 RNA polymerase transcription to therapeutic insight depends on more than yield. Using targeted IL-10 mRNA delivery after ischemic stroke as a case study, this article connects transcript design, mechanistic validation, and translational strategy while showing where the HyperScribe™ T7 High Yield RNA Synthesis Kit can strengthen research workflows.

• Neuritin, ER Stress, and Early Brain Injury After SAH

  2026-09-16

  This study identifies three endoplasmic-reticulum-stress-associated routes that converge on NF-κB to connect subarachnoid hemorrhage with neuroinflammation and neuronal apoptosis. Its central finding is that neuritin overexpression suppresses these pathways, providing a mechanistic framework for studying neuroprotection during early brain injury after SAH.

8492 records 1/567 page Next 12345 下5页 Last page